Schechter Investment Advisors LLC Sells 6,378 Shares of Relx Plc (NYSE:RELX)

Schechter Investment Advisors LLC cut its position in shares of Relx Plc (NYSE:RELX - Free Report) by 17.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 30,102 shares of the technology company's stock after selling 6,378 shares during the quarter. Schechter Investment Advisors LLC's holdings in Relx were worth $1,517,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in RELX. Bank of America Corp DE lifted its stake in shares of Relx by 4.2% during the 4th quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock valued at $283,714,000 after buying an additional 253,107 shares in the last quarter. Lazard Asset Management LLC increased its holdings in shares of Relx by 1.2% in the 4th quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company's stock worth $191,868,000 after buying an additional 48,793 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Relx by 4.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,189,886 shares of the technology company's stock worth $144,885,000 after buying an additional 121,831 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock valued at $127,437,000 after purchasing an additional 2,208,119 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Relx by 51.6% in the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after purchasing an additional 745,532 shares in the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy".

Relx Stock Performance

Shares of RELX stock traded down $0.26 during trading hours on Thursday, reaching $53.49. The company had a trading volume of 730,116 shares, compared to its average volume of 755,192. The business has a fifty day moving average price of $53.67 and a 200-day moving average price of $51.04. Relx Plc has a one year low of $43.45 and a one year high of $56.33. The firm has a market cap of $98.24 billion, a PE ratio of 28.76, a price-to-earnings-growth ratio of 3.50 and a beta of 0.83. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.